{
    "uniprot_canonical_ac": "A0A0R4IXA9-1",
    "uniprot_id": [
        {
            "id": "A0A0R4IXA9_DANRE",
            "url": "https://www.uniprot.org/uniprot/A0A0R4IXA9",
            "type": "external"
        }
    ],
    "mass": 51374.0,
    "length": 468,
    "protein_name": "Adenylyl cyclase-associated protein",
    "gene_name": "cap2",
    "organism": "Zebrafish",
    "refseq_name": "adenylyl cyclase-associated protein 2",
    "refseq_ac": [
        {
            "id": "NP_957130",
            "url": "https://www.ncbi.nlm.nih.gov/protein/NP_957130",
            "type": "external"
        }
    ],
    "gene_names_uniprotkb": "cap2; zgc:113089; zgc:73317",
    "gene_names_refseq": "cap2; zgc:113089; zgc:73317",
    "protein_names_uniprotkb": "Adenylyl cyclase-associated protein",
    "protein_names_refseq": "CAP, adenylate cyclase-associated protein, 2; adenylyl cyclase-associated protein 2",
    "tax_id": 7955,
    "disease": "dilated cardiomyopathy (Disease Ontology:DOID:12930)",
    "pathway": " (dre:393809)",
    "pathway_count": 1,
    "publication_count": 3,
    "publication_id_list": "23022774;23594743;27189481",
    "function": "##Evidence-Data-START## Transcript exon combination :: BC091655.1, SRR32588720.972379.1 [ECO:0000332] RNAseq introns :: single sample supports all introns SAMEA3505370, SAMEA3505371 [ECO:0000348] ##Evidence-Data-END## VALIDATED REFSEQ: This record has undergone validation or preliminary review. The reference sequence was derived from BC091655.1 and JBMGRA010000019.1. On or before May 27, 2016 this sequence version replaced XP_005159849.1, NP_957130.1., [RefSeq]; CAP2 plays an important role in enhancing cell motility, which may promote a more invasive behavior in the progression of hepatocellular carcinoma., [RefSeq, PubMed]",
    "predicted_glycosites": 0,
    "predicted_n_glycosites": 0,
    "predicted_o_glycosites": 0,
    "mined_glycosites": 0,
    "mined_n_glycosites": 0,
    "mined_o_glycosites": 0,
    "reported_n_glycosites": 0,
    "reported_o_glycosites": 0,
    "reported_n_glycosites_with_glycan": 0,
    "reported_o_glycosites_with_glycan": 0,
    "total_reported_n_glycosites": 0,
    "total_reported_o_glycosites": 0,
    "total_n_glycosites": 0,
    "total_o_glycosites": 0,
    "reported_fully_resolved_glycans": 0,
    "reported_phosphosites": 0,
    "reported_mutagensis": 0,
    "reported_glycation": 0,
    "reported_snv": 0,
    "reported_interactions": 0,
    "missing_score": 10000,
    "biomarker_type": "",
    "glycan_count": 0,
    "disease_count": 1,
    "glyco_site_count": 0,
    "binding_glycan_count": 0,
    "secondary_ac_list": "A0A8M6Z2X3",
    "ec_number_list": [],
    "go_molecular_function": "GO:0003779 actin binding;GO:0008179 adenylate cyclase binding",
    "go_cellular_component": "GO:0005737 cytoplasm;GO:0005886 plasma membrane",
    "go_biological_process": "GO:0007015 actin filament organization;GO:0000902 cell morphogenesis;GO:0019933 cAMP-mediated signaling",
    "synthesized_glycan_count": 0,
    "hit_score": 0.4,
    "record_id": "A0A0R4IXA9-1",
    "record_type": "protein",
    "filter_code": "0000000.0000111.100000.0000000000000001.00000.000"
}